Industry News

Abivax Treats First Patient in Phase 2a Rheumatoid Arthritis Clinical Trial of ABX464

lncRNA

Abivax, a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, announced today that the first patient was dosed in study ABX464-301, a phase 2a clinical trial of ABX464 to treat patients with moderate to severe active rheumatoid arthritis (RA). The trial has been fully approved in four countries (France, Poland, ...

Read More »

IQuity lands $150K NIH grant for autoimmune disease research

exosomes

Nashville-based IQuity — which analyzes RNA data to develop tools that help physicians diagnose autoimmune diseases — has received a $150,000 grant from the National Institutes of Health’s Small Business Innovation Research program. The grant will help fund IQuity’s ongoing research into long non-coding RNAs and their usefulness in distinguishing fibromyalgia from rheumatic diseases including rheumatoid arthritis and lupus, according ...

Read More »

RaNA awarded first patent for blocking the interaction of long non-coding RNA with chromatin modifiers

lncRNA

CAMBRIDGE, Mass.-(BUSINESS WIRE)-RaNA Therapeutics, a leader in the discovery and development of a new class of medicines that target RNA, today announced that the United States Patent and Trademark office has issued the first patent covering RaNA’s transcriptional activation platform, U.S. Patent No. 9,328,346, titled “Polycomb-Associated Non-Coding RNAs.” This patent relates broadly to blocking the interaction of long non-coding RNA ...

Read More »

RaNA Therapeutics comes out of stealth, with new CEO, to further RNA targeting for diseases

from Beta Boston by Dennis Keohane RaNA Therapeutics, a company that is using a novel approach to fight disease using RNA, is coming out of stealth today and announcing that Ronald Renaud Jr. will be the company’s new chief executive officer. Founded at the end of 2011 using technology developed by Jeannie Lee, an investigator at the Howard Hughes Medical Institute ...

Read More »

lncRNA Market Trends - Learn the latest about the expanding and evolving long noncoding RNA space.

lncRNA

from Genetic Engineering News by Enal Razvi, Ph.D. The focus of this GEN Market & Tech Analysis report is to present some of our recent industry tracking of the long noncoding RNA (lncRNA) space, as this space is expanding and evolving.Highlights of this report: The lncRNA space is expanding and the numbers of lncRNA sequences deposited in the biological databases ...

Read More »